Kaye Randall
Longboard Pharmaceuticals, Inc. · Executive Vice President & CMO
Kaye Randall is listed in filings as Executive Vice President & CMO at Longboard Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Dec 2, 2024, including sale activity. Recent filings connect the profile to Longboard Pharmaceuticals, Inc. (LBPH). The current snapshot covers public activity from Aug 13, 2024 to Dec 2, 2024. Reported amounts are shown as $2.1M to $1.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $289k9.4k shares | SellSep 16, 2024 | $30.89 | $59.98 | |
| $134k4.2k shares | SellSep 16, 2024 | $31.81 | $59.98 | |
| $65k1.9k shares | SellSep 16, 2024 | $34.04 | $59.98 | |
| $40k1.2k shares | SellSep 16, 2024 | $33.12 | $59.98 | |
| $362k10.5k shares | SellAug 12, 2024 | $34.55 | $59.98 | |
| $217k6.2k shares | SellAug 12, 2024 | $35.03 | $59.98 | |
| $2.1k100 shares | SellJun 25, 2024 | $20.87 | $59.98 |